TapewireFind a company

person · Reporting owner

Lee Chan Henry

Disclosed activity across 1 company

Tapewire entity
23729
SEC CIK
0001980648

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BeOne Medicines Ltd.ONC · Entity 2168SVP, General CounselSeptember 30, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BeOne Medicines Ltd.

Report date September 30, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
American Depositary SharesSEC Table I · non-derivativeDirect0 Reported balance After 2026-09-30 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2026-09-30 · Sale · Disposed 1,115 · Balance 0

F2: Each American Depositary Share represents 13 Ordinary Shares.

F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Ordinary SharesSEC Table I · non-derivativeDirect311,324 Reported balance Holding disclosure · report date 2026-09-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 311,324

F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.

F2: Each American Depositary Share represents 13 Ordinary Shares.

F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 23,348 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 11

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,602

Underlying: Ordinary Shares · 23,348 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 88,426 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 10

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,550

Underlying: Ordinary Shares · 88,426 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 500 $327.93 $163,965.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 9

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 300 $326.80 $98,040.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 500

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 3,318 $325.73 $1,080,760.20
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 800

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.50 to $326.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,776 $325.19 $1,553,123.68
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,118

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.49 to $325.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 296 $159.03 $47,072.88
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 1,796 $213.32 $383,122.72
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 6,802 $194.47 $1,322,784.94
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,112 $325.00 $361,400.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 50,037 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · derivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,758

Underlying: Ordinary Shares · 50,037 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 56,953 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · derivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,976

Underlying: Ordinary Shares · 56,953 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 3,849 $301.00 $1,158,552.85
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.03, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 6,052 $300.19 $1,816,724.46
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,178

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 3,849 $159.03 $612,106.47
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 4,381 $194.47 $851,973.07
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,112 $300.00 $333,600.00
Disclosure

SEC source: 0001628280-25-040535 · wk-form4_1755290322.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
July 30, 2025 Filed Jul 31, 2025 21:04 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 920 $304.60 $280,232.74
Disclosure

SEC source: 0001651308-25-000121 · wk-form4_1753995836.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.5725 to $304.605, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 21:12 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 422 $266.50 $112,463.00
Disclosure

SEC source: 0001651308-25-000114 · wk-form4_1750281121.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 21:49 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantShare Option (Right to Buy) · Derivative 88,244 $0.00 Strike: $20.26 $0.00
Disclosure

SEC source: 0001651308-25-000109 · wk-form4_1749764963.xml · derivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,244

Underlying: Ordinary Shares · 88,244 shares

Expires 2035-06-09

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 21:49 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 46,878 $0.00 $0.00
Disclosure

SEC source: 0001651308-25-000109 · wk-form4_1749764963.xml · nonDerivative · entry 1

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,920

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 230 $256.79 $59,062.67
Disclosure

SEC source: 0001651308-25-000103 · wk-form4_1749589042.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.4629 to $256.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 470 $255.78 $120,217.21
Disclosure

SEC source: 0001651308-25-000103 · wk-form4_1749589042.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.46 to $256.3911, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 05, 2025 Filed Mar 8, 2025 00:20 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 40,209 $0.00 $0.00
Disclosure

SEC source: 0001651308-25-000044 · wk-form4_1741393244.xml · nonDerivative · entry 1

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,142

F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 21:49 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,205 $275.00 $331,375.00
Disclosure

SEC source: 0001651308-25-000037 · wk-form4_1741038558.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 22:04 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $260.22 $26,021.50
Disclosure

SEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 22:04 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 598 $258.69 $154,699.25
Disclosure

SEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.48 to $259.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 22:04 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 504 $256.84 $129,448.97
Disclosure

SEC source: 0001651308-25-000020 · wk-form4_1740521076.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 698

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.74 to $257.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 23:13 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,202 $237.10 $284,994.20
Disclosure

SEC source: 0001651308-24-000127 · wk-form4_1727910822.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.

Read SEC document
July 30, 2024 Filed Aug 1, 2024 21:06 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 834 $160.57 $133,915.38
Disclosure

SEC source: 0001651308-24-000092 · wk-form4_1722546357.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 21:24 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 129 $159.74 $20,605.85
Disclosure

SEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.40 to $160.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 21:24 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 208 $159.68 $33,213.23
Disclosure

SEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.12 to $159.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 17, 2024 Filed Jun 20, 2024 21:24 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 102 $158.20 $16,135.93
Disclosure

SEC source: 0001651308-24-000071 · wk-form4_1718918661.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.10 to $159.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:03 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantShare Option (Right to Buy) · Derivative 184,795 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000066 · wk-form4_1717794184.xml · derivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,795

Underlying: Ordinary Shares · 184,795 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:03 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 98,085 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000066 · wk-form4_1717794184.xml · nonDerivative · entry 1

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,399

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
July 31, 2023 Filed Aug 2, 2023 21:10 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 791 $216.26 $171,059.05
Disclosure

SEC source: 0001651308-23-000128 · wf-form4_169101062121566.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 29, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.068 to $216.2962, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 22:55 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantShare Option (Right to Buy) · Derivative 248,950 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001651308-23-000093 · wf-form4_168730171982754.xml · derivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,950

Underlying: Ordinary Shares · 248,950 shares

Expires 2033-06-14

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 22:55 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 65,585 $0.00 $0.00
Disclosure

SEC source: 0001651308-23-000093 · wf-form4_168730171982754.xml · nonDerivative · entry 1

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,597

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.